These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37750290)

  • 1. Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the ERK/DNMT1/ACSL4 axis.
    Zou P; Chen Z; He Q; Zhuo Y
    Prostate; 2024 Jan; 84(1):64-73. PubMed ID: 37750290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
    Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer.
    Zhou X; Zou L; Chen W; Yang T; Luo J; Wu K; Shu F; Tan X; Yang Y; Cen S; Li C; Mao X
    Pharmacol Res; 2021 Feb; 164():105305. PubMed ID: 33197601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk of NF-κB/P65 and LncRNA HOTAIR-Mediated Repression of MUC1 Expression Contribute to Synergistic Inhibition of Castration-Resistant Prostate Cancer by Polyphyllin 1-Enzalutamide Combination Treatment.
    Xiang S; Zou P; Wu J; Zheng F; Tang Q; Zhou J; Hann SS
    Cell Physiol Biochem; 2018; 47(2):759-773. PubMed ID: 29807357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
    Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
    Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration-resistant prostate cancer.
    Zhang H; Zhou Y; Feng Y; Hou W; Chen Y; Xing Z; Zhang Y; Wei Q; Yin Y; Guo J; Hu H
    Clin Transl Med; 2024 May; 14(5):e1678. PubMed ID: 38736108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis.
    Jin Z; Gao W; Guo F; Liao S; Hu M; Yu T; Yu S; Shi Q
    J Neurochem; 2023 Jul; 166(2):328-345. PubMed ID: 37300304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
    Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
    J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy
    Zhou X; Zou L; Liao H; Luo J; Yang T; Wu J; Chen W; Wu K; Cen S; Lv D; Shu F; Yang Y; Li C; Li B; Mao X
    Acta Pharm Sin B; 2022 Feb; 12(2):692-707. PubMed ID: 35256940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
    Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
    Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis inducer erastin downregulates androgen receptor and its splice variants in castration‑resistant prostate cancer.
    Yang Y; Liu T; Hu C; Xia H; Liu W; Chen J; Wu S; Jiang Y; Xu Y; Liu W; Zhao L
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p/ACSL4 axis.
    Yu Q; Zhang N; Gan X; Chen L; Wang R; Liang R; Jian J
    Phytomedicine; 2023 Oct; 119():154999. PubMed ID: 37597361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.
    Linder A; Larsson K; Welén K; Damber JE
    Prostate; 2020 Aug; 80(11):799-810. PubMed ID: 32449815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maresin-1 inhibits high glucose induced ferroptosis in ARPE-19 cells by activating the Nrf2/HO-1/GPX4 pathway.
    Li Y; Liu J; Ma X; Bai X
    BMC Ophthalmol; 2023 Sep; 23(1):368. PubMed ID: 37674121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1
    Cao H; Wu X; Gao R; Chen L; Feng Y; Wang D
    J Cancer; 2023; 14(12):2236-2245. PubMed ID: 37576395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPX2 overexpression is involved in cell proliferation and prognosis of castration-resistant prostate cancer.
    Naiki T; Naiki-Ito A; Asamoto M; Kawai N; Tozawa K; Etani T; Sato S; Suzuki S; Shirai T; Kohri K; Takahashi S
    Carcinogenesis; 2014 Sep; 35(9):1962-7. PubMed ID: 24562575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the KIF4A/AR Axis to Reverse Endocrine Therapy Resistance in Castration-resistant Prostate Cancer.
    Cao Q; Song Z; Ruan H; Wang C; Yang X; Bao L; Wang K; Cheng G; Xu T; Xiao W; Xiong Z; Liu D; Yang M; Zhou D; Yang H; Chen K; Zhang X
    Clin Cancer Res; 2020 Mar; 26(6):1516-1528. PubMed ID: 31796514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
    Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of sorafenib and enzalutamide as a potential new approach for the treatment of castration-resistant prostate cancer.
    Wu H; Zhang L; Gao X; Zhang X; Duan J; You L; Cheng Y; Bian J; Zhu Q; Yang Y
    Cancer Lett; 2017 Jan; 385():108-116. PubMed ID: 27815035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis.
    Sun R; Yan B; Li H; Ding D; Wang L; Pang J; Ye D; Huang H
    Cancer Res; 2023 Oct; 83(19):3192-3204. PubMed ID: 37527336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.